Open Access

Rosavin exerts an antitumor role and inactivates the MAPK/ERK pathway in small-cell lung carcinoma in vitro

Rui Liu

Rui Liu

Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus)Beijing, China
Search for this author on
Sciendo|Google Scholar
Liu, Rui
, 
Cuihong Jiang

Cuihong Jiang

Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus)Beijing, China
Search for this author on
Sciendo|Google Scholar
Jiang, Cuihong
, 
Zhizheng Zhao

Zhizheng Zhao

Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus)Beijing, China
Search for this author on
Sciendo|Google Scholar
Zhao, Zhizheng
, 
Yutong Lv

Yutong Lv

Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus)Beijing, China
Search for this author on
Sciendo|Google Scholar
Lv, Yutong
 and 
Gaoxing Wang

Gaoxing Wang

Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus)Beijing, China
Search for this author on
Sciendo|Google Scholar
Wang, Gaoxing
  
Jun 12, 2023
Rosavin exerts an antitumor role and inactivates the MAPK/ERK pathway in small-cell lung carcinoma in vitro's Cover Image
About this article
Previous Article
Next Article
Cite
Download Cover
Published Online: Jun 12, 2023
Page range: 269 - 280
Accepted: Dec 03, 2022
DOI: https://doi.org/10.2478/acph-2023-0015
Keywords
© 2023 Rui Liu et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Pharmacy, Pharmacy, other
Journal RSS Feed